<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00478439</url>
  </required_header>
  <id_info>
    <org_study_id>F070410002</org_study_id>
    <nct_id>NCT00478439</nct_id>
  </id_info>
  <brief_title>Investigation of Macular Pigment Augmentation on Dark Adaptation</brief_title>
  <official_title>Investigation of Macular Pigment Augmentation on Dark Adaptation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ZeaVision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will evaluate whether taking a nutritional supplement designed to increase macular
      pigment in the eye can improve a person's ability to adjust to darkness. Patients will be
      assigned to take either a placebo or nutritional supplement for 8 months. Vision will be
      assessed at baseline, 4 months, and 8 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study design is a randomized, double-blinded, placebo-controlled intervention study that
      will evaluate whether macular pigment augmentation improves the speed of dark adaptation. Two
      groups of participants will be enrolled, old adults with normal vision and early age-related
      macular degeneration patients. Macular pigment will be augmented using EyePromise RESTORE
      (ZeaVision, Inc). EyePromise RESTORE is a nutritional supplement that has been found to
      increase macular pigment levels in some users. Macular pigment level and the speed of dark
      adaptation (how fast a person adjusts to the dark) will be assessed at baseline, 4-months,
      and 8-months. Fundus appearance will be assessed at baseline and 8-months follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study terminated: Recruitment delay due to equipment malfunction
  </why_stopped>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">September 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dark Adaptation</measure>
    <time_frame>Measured 3 times over 8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Macular Pigment Density</measure>
    <time_frame>Measured 3 times over 8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Aging</condition>
  <condition>Age-Related Macular Degeneration</condition>
  <arm_group>
    <arm_group_label>Placebo Comparator</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>ZeaVision EyePromise Restore</intervention_name>
    <description>Vitamin C 120mg, Vitamin E 60IU, Zinc 15mg, Fish Oil 250mg, Omega 3 125mg, Alphaliploic acid 10mg, Zeaxanthin 8mg,mixed tocopherols 6mg, lutein 4mg,</description>
    <arm_group_label>Placebo Comparator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamin</intervention_name>
    <description>Vitamin C 120mg, Vitamin E 60IU, Zinc 15mg, Fish Oil 250mg, Omega 3 125mg, Alphaliploic acid 10mg, mixed tocopherols 6mg, lutein 4mg,</description>
    <arm_group_label>Placebo Comparator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  60 to 80 years old

          -  &lt; +- 4.00 diopters spherical equivalent

          -  normal eye health or early age-related macular degeneration

        Exclusion Criteria:

          -  neurological conditions that can impair vision

          -  diabetes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leo P Semes, O.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UAB School of Optometry</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2007</study_first_submitted>
  <study_first_submitted_qc>May 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2007</study_first_posted>
  <last_update_submitted>October 26, 2010</last_update_submitted>
  <last_update_submitted_qc>October 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Leo P. Semes, O.D./Principal Investigator</name_title>
    <organization>UAB School of Optometry</organization>
  </responsible_party>
  <keyword>aging</keyword>
  <keyword>age-related macular degeneration</keyword>
  <keyword>macular pigment</keyword>
  <keyword>dark adaptation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

